Keyphrases
Minimally Invasive
100%
Glioblastoma
100%
Glioblastoma multiforme
100%
Sensitive Detection
100%
Circulating Tumor DNA (ctDNA)
100%
Brain Tumor
50%
Brain Cancer
50%
Liquid Biopsy
50%
Blood-brain Barrier
33%
Tumor-specific
33%
Diagnostic Sensitivity
33%
Blood-based
33%
Focused Ultrasound
33%
Genetic mutation
33%
Blood-brain Barrier Permeability
33%
C228T
33%
Ultrasound Sonication
33%
EGFRvIII
33%
Magnetic Resonance Imaging
16%
Tumor DNA
16%
Contrast Enhancement
16%
Porcine
16%
Molecular Characterization
16%
Cancer Management
16%
T1-weighted
16%
Clinical Translation
16%
Permeability Change
16%
Genomic Characterization
16%
Droplet Digital PCR (ddPCR)
16%
Molecular Biomarkers
16%
Tissue Damage
16%
Clinical Risk
16%
Histological Staining
16%
Blood Circulation
16%
Converging Evidence
16%
Surgical Biopsy
16%
Detection Sensitivity
16%
Sensitive Diagnosis
16%
Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
16%
Translational Implications
16%
Medicine and Dentistry
Glioblastoma
100%
Sensitive Detection
100%
Circulating Tumor DNA
100%
Blood Brain Barrier
57%
Brain Cancer
42%
Liquid Biopsy
42%
Intracranial Tumor
42%
Diagnosis
28%
Neoplasm
28%
Gene Mutation
28%
Specific Tumor
28%
Biological Marker
14%
Magnetic Resonance Imaging
14%
Target Tissue
14%
Tissue Injury
14%
Biopsy Technique
14%
Circulation
14%
Droplet Digital Polymerase Chain Reaction
14%
Histology
14%
Neuroscience
Glioblastoma Multiforme
100%
Circulating Tumor DNA
100%
Blood Brain Barrier
66%
Brain Cancer
50%
Intracranial Tumor
50%
Gene Mutation
33%
Magnetic Resonance Imaging
16%
Droplet Digital Polymerase Chain Reaction
16%
Histology
16%
Biochemistry, Genetics and Molecular Biology
Blood Brain Barrier
100%
Circulating Tumor DNA
100%
Gene Mutation
50%
Ultrasound
50%
Pig
25%
Target Tissue
25%
Droplet Digital Polymerase Chain Reaction
25%
Circulation
25%
Genomics
25%
Magnetic Resonance Imaging
25%